| Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification S Chidambaranathan-Reghupaty, PB Fisher, D Sarkar Advances in cancer research 149, 1-61, 2021 | 458 | 2021 |
| Current status of gene therapy in hepatocellular carcinoma SC Reghupaty, D Sarkar Cancers 11 (9), 1265, 2019 | 58 | 2019 |
| The multifaceted oncogene SND1 in cancer: focus on hepatocellular carcinoma S Chidambaranathan-Reghupaty, R Mendoza, PB Fisher, D Sarkar Hepatoma research 4, 2018 | 21 | 2018 |
| Mouse bone marrow cell isolation and macrophage differentiation R Mendoza, I Banerjee, D Manna, SC Reghupaty, R Yetirajam, D Sarkar Non-Alcoholic Steatohepatitis: Methods and Protocols, 85-91, 2022 | 8 | 2022 |
| Melanoma differentiation associated gene‐9/syndecan binding protein promotes hepatocellular carcinoma D Manna, SC Reghupaty, MDC Camarena, RG Mendoza, MA Subler, ... Hepatology 78 (6), 1727-1741, 2023 | 6 | 2023 |
| Dissecting the balance between metabolic and oncogenic functions of astrocyte‐elevated gene‐1/metadherin Y Rajesh, SC Reghupaty, RG Mendoza, D Manna, I Banerjee, MA Subler, ... Hepatology communications 6 (3), 561-575, 2022 | 6 | 2022 |
| Isolation and culture of mouse hepatocytes and kupffer cells (KCs) R Mendoza, I Banerjee, SC Reghupaty, R Yetirajam, D Manna, D Sarkar Non-Alcoholic Steatohepatitis: Methods and Protocols, 73-84, 2022 | 6 | 2022 |
| AEG-1 targeting for inhibiting inflammation: potential anti-HCC strategy SC Reghupaty, R Mendoza, D Sarkar Oncotarget 10 (6), 629, 2019 | 4 | 2019 |
| TAF2: a potential oncogene for hepatocellular carcinoma S Chidambaranathan Reghupaty | 1 | 2017 |
| Dysregulation of Type I Interferon (IFN-I) Signaling: A Potential Contributor to Racial Disparity in Hepatocellular Carcinoma (HCC) SC Reghupaty, S Kanwal, RG Mendoza, E Davis, H Li, Z Lai, ... Cancers 15 (17), 4283, 2023 | | 2023 |
| Melanoma differentiation associated gene-9/syndecan binding protein (mda-9/sdcbp): A positive regulator of hepatocellular carcinoma D Manna, SC Reghupaty, RG Mendoza, MD Camarena, MA Subler, ... Cancer Research 82 (12_Supplement), 920-920, 2022 | | 2022 |
| TAF2 and MYC: Cooperation Between Co-amplified Genes Promotes Hepatocellular Carcinoma SC Reghupaty Virginia Commonwealth University, 2022 | | 2022 |
| TAF2 and MYC: Cooperation Between Co-amplified Genes Promotes Hepatocellular Carcinoma S Chidambaranathan Reghupaty | | 2022 |
| Interrogating chromosome 8q amplification in hepatocellular carcinoma S Reghupaty, R Mendoza, M Dozmorov, P Fisher, K Ebeid, A Salem, ... JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 34, 38-38, 2019 | | 2019 |
| Unraveling the molecular mechanism of racial disparity in hepatocellular carcinoma (HCC): A link between type I interferon (IFN-I) signaling and HCC disparity S Chidambaranathan-Reghupaty, M Dozmorov, R Mendoza, Z Lai, ... Cancer Research 79 (13_Supplement), 4001-4001, 2019 | | 2019 |
| TAF2: A Potential Oncogene for Hepatocellular Carcinoma SC Reghupaty Virginia Commonwealth University, 2017 | | 2017 |
